ways to connect


27 January 2016
SonarMed receives FDA clearance for real-time monitoring device for endotracheal tubes in pediatric patientsCarmel, Indi...



about SonarMed®

SonarMed® was founded in 2005 to commercialize technology licensed from Purdue University to improve the placement and monitoring of endotracheal tubes (also known as ETTs or artificial airways) that are used in patients who cannot breathe on their own.
The technology was initially developed at Purdue University by SonarMed founders Dr. Jeffrey Mansfield, Dr. Eduardo Juan, and Dr. George Wodicka, using the principles of acoustic reflectometry to provide the medical community with a more comprehensive approach to assist in the management of endotracheal tubes.
The company’s first product – the SonarMed® AirWave™– is a non invasive, adjunctive device that provides direct, precise, real time monitoring of endotracheal tube position and function, which may aid in detecting potentially dangerous or fatal endotracheal tube conditions. The AirWave™ may help reduce endotracheal tube related risks and complications, thereby improving patient safety and quality of care as well as reducing cost of care.
Development of the SonarMed® AirWave™ was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health and the Indiana 21st Century Research and Technology Fund.



For the recent news, please visit our news page.



For upcoming events, please visit our events page.